BERLIN: Clinical trials on humans have begun in China for a potential coronavirus vaccine developed by German pharmaceutical group BioNTech with Chinese company Fosun Pharma, the companies said Wednesday .
Another, BNT162b2, is being evaluated in a global phase 3 trial conducted by BioNTech and US giant Pfizer which started on Jul 27.Those aged 18-55 will be the first to take part, followed by older people.Laboratories around the world are racing to find a vaccine to curb COVID-19, which has claimed more than 700,000 lives and upended the livelihoods of millions.
Several Chinese companies are at the forefront of the global vaccine race, while Russia has said it hopes to be the first in the world to produce a vaccine for the public, with a target date of September.